Sacituzumab Govitecan in Untreated, Advanced Triple-Negative Breast Cancer
New England Journal of Medicine · 13.11.2025 · 393 (19) · 1912-1925
DOI: 10.1056/nejmoa2511734 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift New England Journal of Medicine, erschienen am 13.11.2025. Verfasst von Javier Cortés und 18 weiteren Autor:innen. Beteiligte Einrichtung: International Breast Cancer Center, Pangaea Oncology, Quiron Group, Barcelona. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Humanized, Antineoplastic Agents, Antineoplastic Combined Chemotherapy Protocols, Camptothecin. Die Arbeit wurde bisher 119-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Gilead Sciences.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- International Breast Cancer Center, Pangaea Oncology, Quiron Group, Barcelona.
- IOB Madrid, Institute of Oncology, Hospital Beata María Ana, Madrid.
- Oncology Department, Hospital Universitario Torrejón, Ribera Salud Group, Madrid.
- Universidad Europea de Madrid, Faculty of Biomedical and Health Sciences, Department of Medicine, Madrid.
- Medica Scientia Innovation Research, Barcelona.
- Medica Scientia Innovation Research, Ridgewood, NJ.
ORCID-Profile: Joohyuk Sohn
Förderung
- Gilead Sciences
Zitieren
APA
Cortés, J., Punie, K., Barrios, C., Hurvitz, S. A., Schneeweiss, A., Sohn, J., Tokunaga, E., Brufsky, A., Park, Y. H., Xu, B., Hegg, R., Oliveira, M., Fabi, A., Vaksman, N., Valdez, T., Zhang, X., Lai, C., Tolaney, S. M., & ASCENT-03 Clinical Trial Investigators (2025). Sacituzumab Govitecan in Untreated, Advanced Triple-Negative Breast Cancer. New England Journal of Medicine, 393(19), 1912-1925. https://doi.org/10.1056/nejmoa2511734
Vancouver
Cortés J, Punie K, Barrios C, Hurvitz SA, Schneeweiss A, Sohn J, et al. Sacituzumab Govitecan in Untreated, Advanced Triple-Negative Breast Cancer. New England Journal of Medicine. 2025;393(19):1912-1925. doi:10.1056/nejmoa2511734
BibTeX
@article{Corts2025,
author = {Cortés, Javier and Punie, Kevin and Barrios, Carlos and Hurvitz, Sara A and Schneeweiss, Andreas and Sohn, Joohyuk and Tokunaga, Eriko and Brufsky, Adam and Park, Yeon Hee and Xu, Binghe and Hegg, Roberto and Oliveira, Mafalda and Fabi, Alessandra and Vaksman, Natalya and Valdez, Theresa and Zhang, Xinrui and Lai, Catherine and Tolaney, Sara M and ASCENT-03 Clinical Trial Investigators, ASCENT-03 Clinical Trial Investigators},
title = {Sacituzumab Govitecan in Untreated, Advanced Triple-Negative Breast Cancer},
journal = {New England Journal of Medicine},
year = {2025},
volume = {393},
number = {19},
pages = {1912--1925},
doi = {10.1056/nejmoa2511734}
}
EUVIMED